An Experimental Second-Harmonic Axis-Encircling Beam Gyro-TWT
Despite the bright potential as a broad band source for future radar and communication applications, the area of harmonic gyro-TWTs with axis-encircling beams has been relatively unexplored. A second-harmonic TE21 gyro-TWT has been constructed at UCD that is predicted to produce 50 kW in Ka-band with 20% efficiency, 30 dB saturated gain and 3% bandwidth and is ready for hot testing. The device is driven by an axis-encircling electron beam from a novel Northrop Grumman cusp gun.
Cusp gun TE/sub 21/ second-harmonic Ka-band gyro-TWT amplifier
A second-harmonic TE/sub 21/ gyrotron traveling-wave tube (gyro-TWT) amplifier with an axis-encircling electron beam is being constructed at the University of California-Davis that is predicted to double the efficiency of our previous 200-kW 12%-efficient magnetron injection gun (MIG) TE/sub 21//sup (2)/ gyro-TWT. Both devices employ a sliced mode-selective circuit to suppress the odd-order azimuthal modes. The new device will avoid the loss in efficiency that is due to off-axis electrons interacting with the resulting linearly polarized mode. The amplifier is predicted by our large signal code to produce 50 kW in Ka-band with 20% efficiency, 30 dB saturated gain, and 3% bandwidth. The 70-kV 3.5-A axis-encircling electron beam with /spl upsi//sub /spl perp////spl upsi//sub z/ = 1.2 and /spl Delta//spl upsi//sub z///spl upsi//sub z/ = 7% will be produced by a Cusp electron gun delivered by Northrop Grumman. The amplifier has been designed using linear theory to provide a 30% safety margin from absolute instability. Distributed loss is added to the first 30.5 cm of the circuit to ensure the device is stable to harmonic gyro-BWO. The last 11.5 cm of the circuit is standard copper to avoid attenuating the wave at high power levels.
A quality control model that uses PTV-rectal distances to predict the lowest achievable rectum dose, improves IMRT planning for patients with prostate cancer.
BACKGROUND AND PURPOSE
To predict the lowest achievable rectum D35 for quality assurance of IMRT plans of prostate cancer patients.


MATERIALS AND METHODS
For each of 24 patients from a database of 47 previously treated patients, the anatomy was compared to the anatomies of the other 46 to predict the minimal achievable rectum D35. The 24 patients were then replanned to obtain maximally reduced rectum D35. Next, the newly derived plans were added to the database to replace the original clinical plans, and new predictions of the lowest achievable rectum D35 were made.


RESULTS
After replanning, the rectum D35 reduced by 9.3 Gy±6.1 (average±1 SD; p<0.001) compared to the original plan. The first predictions of the rectum D35 were 4.8 Gy±4.2 (average±1 SD; p<0.001) too high when evaluated with the new plans. After updating the database, the replanned and newly predicted rectum D35 agreed within 0.1 Gy±2.8 (average±1 SD; p=0.89). The doses to the bladder, anus and femoral heads did not increase compared to the original plans.


CONCLUSIONS
For individual prostate patients, the lowest achievable rectum D35 in IMRT planning can be accurately predicted from dose distributions of previously treated patients by quantitative comparison of patient anatomies. These predictions can be used to quantitatively assess the quality of IMRT plans.